Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell immunity using transgenic B lymphocytes.

Mara Gerloni1, Marta Rizzi, Paola Castiglioni

  • 1Department of Medicine and Cancer Center, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0837, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Immunophenotyping Reveals Distinct Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Time-resolved immune dynamics in rheumatoid arthritis under methotrexate therapy.

Annals of the rheumatic diseases·2026
Same author

Triple-negative breast cancer, pregnancy, and HLA alloreactivity: a cause for concern?

Frontiers in oncology·2026
Same author

IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

The Journal of experimental medicine·2026
Same author

NeoPrecis: enhancing immunotherapy response prediction through integration of qualified immunogenicity and clonality-aware neoantigen landscapes.

Nature communications·2026
Same author

A viral glycoprotein targets IgG<sup>+</sup> memory B cells to mediate humoral immune evasion.

EMBO molecular medicine·2026

Mature B lymphocytes can be genetically programmed to become potent antigen-presenting cells, initiating T cell responses without dendritic cells and paving the way for novel vaccination strategies.

Area of Science:

  • Immunology
  • Cell Biology
  • Vaccinology

Background:

  • Adaptive immunity is crucial for defense against pathogens and tumors.
  • T cell responses are initiated by antigen presentation, typically by dendritic cells.
  • Current understanding limits antigen-presenting cell capabilities to specific cell types.

Purpose of the Study:

  • To investigate the potential of genetically programmed B lymphocytes as antigen-presenting cells.
  • To determine if B cells can stimulate T cell responses in vivo without dendritic cells.
  • To explore novel vaccination strategies based on engineered antigen-presenting cells.

Main Methods:

  • Genetic programming of mature naïve B lymphocytes using nonviral DNA.
  • In vivo administration of transgenic B lymphocytes via intravenous injection.

Related Experiment Videos

  • Assessment of T cell activation, priming, and immunological memory induction.

    • Main Results:

    • Genetically programmed B lymphocytes function as potent antigen-presenting cells.
    • Successful in vivo T cell activation and specific responses were achieved with low cell doses.
    • T cell priming and protective immunological memory were established independently of dendritic cells.

    Conclusions:

    • Mature B lymphocytes can be engineered into effective antigen-presenting cells.
    • Dendritic cell-independent T cell priming is feasible, leading to protective immunity.
    • This approach offers new possibilities for developing vaccines against viral infections and cancer.